Not true.
http://www.smh.com.au/business/melbo...08-12kawp.html
Printable View
From your link below
"The big play for Sienna is to create its own tests using the reagent. Ms Hegarty said over the next two months she will decide whether it is best to raise the $10 million from the public or private market. The capital will be used to gain regulatory approvals for the company's own tests."
Says it all really.
Still has to jump through the hoops.
So hows it all going? That all came out about a year ago.
Good luck with the approvals, it takes a while , just ask PEB.
I dont see a distributor in all that either. I see Borthwick Labs utilising a test from an unlisted biotech.
QUOTE=Balance;646985]Not true.
http://www.smh.com.au/business/melbo...08-12kawp.html[/QUOTE]
All of us can look at CX and think of all the advantages-but unfortunately that just doesnt cut the mustard--Trump is not going to think about a micro little bladder cancer test--He is going to go for some big mega change that fits in with his somewhat chaotic master plan.All we can do is try to keep up with what he has in mind(which is not easy for reason already stated)--We do know he wants to dismantle lots of what is in place.There is talk of not only trashing Obamacare (how much? all of it?) but also doing the same with Medicare---time will tell ,but thats the talk---We can only wait,and in the mean time look at the direction it appears to be moving.---Atm he does not appear to be a friend to the health sector,unless perhaps you are a mega pharmaceutical co.
This is a time when,I think ,we have no choice but to think Macro
As depressing as it sounds ,I would venture the opinion that everyone does not indeed have to jump through the same hoops.Large established companies have an advantage--they have lots of influence in the form of lobbyists and just plain clout--thats just how it works in the States (why do you think some oil company man is minister of the environment) sad but true---it is not the level playing field one would hope.
Strong buying from institutional investors..... Just saying it before balance does hehe. Mind you he may still be correct with his analogy about this company only time will tell
Paul Ryan -GOP speaker-says first thing they'll do is scrap Obama care-(to take affect in 3 years as they figure out something better)---and change Medicare as it is ''burning a hole in the budget''
http://www.marketwatch.com/story/spe...ry_top_stories
DYOR
Well why not go for an alternative test that is far less intrusive, far more accurate and costs a third of the current option.....a warmer more soothing hole in the snow/budget.
That would be great if you were the one making the decisions--What comes first is the grand plan--(as it looks now ,its cuts) then ,later down the line someone makes those small decisions on micro companies and their test--(PEB is but a flea on the back of a knat on a big ole dog---It can be the greatest test in the world and still fall through the bureaucratic cracks while everyone is trying to make up their minds on what to do---Dont forget the specialists have reason to protect cytology----New innovations do not always do well in an environment of cut backs...Its looking like Medicare has far more important things to think about ATM.
Better than not that PEB has a good product that can potentially save money(most however would still do cytology)--but that alone does not open doors---It just gives you a chance to open doors---that chance is going to be harder Imo---(now if they made some spiffy new military gadget--(thats where the dosh is going)
Read my lips--Trump does not care about things that are for looking after the people,or the planet.
I wonder when the next Edison is due to come out. I know some of you might accuse Edison and Forsyth Barr Research of being the mouth piece of the company (or cheerleaders) but I'm interested to see how much their $1.19 price has moved.